CL
Colgate-PalmolivePrevious close
87.02
Change
+0.02 / +0.02%
52-Week Range
74.55 – 99.33
P/E (TTM)
34.0
Forward P/E
23.2
Based on consensus earnings for the next 12 months
Market Cap
$69.4B
1M
−3.54%
S&P 500 −2.41% over same period
Volume / Avg Volume
5.9M / 4.7M
1.24× average
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | EPS Actual / Est. | Analysis |
|---|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-31 | $5.4B | 0.99 / 0.98 | Pending |
| FY2026 Q1 Quarter ended 2026-03 | 2026-05-01 | $5.3B | 0.97 / 0.97 | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-01-30 | — | — / — | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-31 | — | — / — | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-08-01 | — | — / — | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-25 | — | — / — | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 70 of its 5-year rangeExpensive
5-year range 22.1 – 41.6 · Median 30.4
Last 4 quarters: $1.3B in buybacks + $0 in dividends, 1.86% of market cap combined
P/E (TTM)
34.0
P/B
—
P/S
3.3
Dividend Yield
2.48%
Earnings Reaction
Over the last 6 reports, the stock moved ±1.9% on average on the first trading day after, rising 1 times
Most recent −1.56%
Volatility & Correlation
1-year beta -0.14 · Correlation with S&P 500 -0.08Low beta
Annualized volatility 23% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 4 · $31.0MNet selling $31.0M
- 08-24Tsourapas PanagiotisCOO, CD, EMEA, APac, SkinSell$0.92M10,000 shares · Avg price 92.05
- 08-06CAHILL JOHN TDirectorSell$0.39M4,170 shares · Avg price 93.37
- 08-05Wallace Noel R.Chairman, President & CEOSell$14.9M161,021 shares · Avg price 92.52
- 08-04Wallace Noel R.Chairman, President & CEOSell$14.8M161,021 shares · Avg price 91.92
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q2 | 5.36 | +4.9% | 61.5% | 0.69 | 0.86 |
| FY2026 Q1 | 5.32 | +8.4% | 60.6% | 0.65 | 0.80 |
| FY2025 Q4 | 5.23 | +5.8% | 60.2% | -0.04 | -0.04 |
| FY2025 Q3 | 5.13 | +1.9% | 59.4% | 0.74 | 0.91 |
| FY2025 Q2 | 5.11 | +1.0% | 60.1% | 0.74 | 0.91 |
| FY2025 Q1 | 4.91 | −3.0% | 60.8% | 0.69 | 0.85 |
| FY2024 Q4 | 4.95 | −0.1% | 60.3% | 0.74 | 0.89 |
| FY2024 Q3 | 5.03 | +2.4% | 61.1% | 0.74 | 0.90 |
| FY2024 Q2 | 5.06 | +4.9% | 60.6% | 0.73 | 0.89 |
| FY2024 Q1 | 5.07 | +6.2% | 60.0% | 0.68 | 0.83 |
| FY2023 Q4 | 4.95 | +6.9% | 59.6% | 0.72 | 0.86 |
| FY2023 Q3 | 4.92 | +10.3% | 58.5% | 0.71 | 0.86 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| CL | 34.0 | +4.9% | 61.5% | −3.54% | Neutral |
| WMT | 38.5 | +5.9% | 25.4% | −5.97% | Neutral |
| COST | 45.2 | +11.6% | 12.8% | −6.27% | Bullish |
| KO | 26.6 | −0.5% | 63.0% | +1.02% | Neutral |
| PG | 21.2 | +1.5% | 48.5% | +2.72% | Neutral |
| PM | 27.8 | +10.4% | 68.4% | +3.90% | Neutral |
| PEP | 17.7 | +6.4% | 54.2% | −2.82% | Neutral |
| MO | 14.6 | +0.1% | 74.9% | +9.60% | Neutral |
| MNST | 41.3 | +20.2% | 55.9% | −2.09% | Neutral |